Renovaro Biosciences Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -9.28 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
1.17 | 4.83 | -75.68% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-1.99 | -22.17 | -91.01% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-14.36 | 68.76 | -120.88% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | -5197.5 | -100% |
| ROE |
|
-90.37 | 9.61 | -1040.27% |
|
|
| ROA |
|
-72.84 | 0.3443 | -21259.84% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-59.96 | 15.45 | -488.1% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0476 | -3.68 | -98.7% | -0.1905 | -75% |
| Nеt Debt/Ebitda |
|
-0.0449 | -3.44 | -98.7% |
|
|
| Debt/Ratio |
|
0.0232 | 0.1986 | -88.31% |
|
|
| Debt/Equity |
|
2.66 | 1.66 | 60.09% |
|
|
| Debt/Net Income |
|
-0.047 | 10.32 | -100.45% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
42.56 | -57.64 | -173.84% | ||
| Growth impulse Ebitda in 5 years |
|
609.97 | -90.94 | -770.74% | ||
| Growth impulse Net Income in 5 years |
|
607.46 | -97.8 | -721.12% | ||
| Growth impulse FCF in 5 years |
|
4.17 | -108.72 | -103.84% | ||
| Growth impulse EPS in 5 years |
|
241.32 | -142.05 | -269.88% |
IP Score
3.91/10
